Regional Fish Institute Ltd. in Japan is now accepting orders on a crowdfunding site for genetically manipulated farmed red sea bream that boasts 1.2 times thicker flesh than ordinary farmed ones.
Sales are initially restricted to 190 customers with deliveries expected to start in October. The production process is explained in detail with each purchase.
Kyoto University and Kindai University developed the fleshier fish variant by rendering a gene called myostatin that controls muscle growth.
The Regional Fish Institute, a biotech enterprise affiliated with Kyoto University, registered the commercialization of its “genome-edited food” with the government on Sept. 17.
On the same day, the health ministry declared that no safety examinations were required.
Genome editing, which aims to destroy or introduce particular genes, is also applied for increasing harvest yields in rice and other plant varieties.
As no foreign genes from other species were introduced into genome-processed items, as with genetic recombination, no safety checks were necessary.
This method is essentially the same as traditional selective breeding methods to create improved varieties.
The institute's sea bream is the first genome-edited animal product to be marketed in Japan.


SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Tabletop particle accelerator could transform medicine and materials science
Lab-grown meat: you may find it icky, but it could drive forward medical research
BOJ Faces Pressure for Clarity, but Neutral Rate Estimates Likely to Stay Vague
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows
Asian Currencies Steady as Rupee Hits Record Low Amid Fed Rate Cut Bets
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Neuralink Expands Brain Implant Trials with 12 Global Patients
Japan’s Nikkei Drops as Markets Await Key U.S. Inflation Data
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 



